Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04634071 · ClinicalTrials.gov registry record · Phase 2
Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment
A Phase 2 study of Smoking Cessation and Cancer, Treatment-Related, sponsored by Joseph Valentino, MD.
- Completed
- Registry status
- Phase 2
- Development phase
- 126
- Enrollment target
- 3
- Study locations
NCT04634071: Completed Phase 2 study of Smoking Cessation and Cancer, Treatment-Related, sponsored by Joseph Valentino, MD.
NCT04634071 is a Phase 2 study of Smoking Cessation and Cancer, Treatment-Related that has completed, run by Joseph Valentino, MD. The registered enrollment target is 126 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (73% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04634071, a Phase 2 study of Smoking Cessation and Cancer, Treatment-Related, has completed, sponsored by Joseph Valentino, MD.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 126 participants
- Enrollment target
- 3
- Study locations
Study Summary
Smoking cessation has been shown to improve the effectiveness and reduce the morbidity of tobacco-related cancer treatments. We will identify effective smoking cessation strategies for patients who are receiving treatment for tobacco-related cancer. In this trial, patients' preferences in smoking cessation therapy will be the principal determinant by providers in developing a three component regimen of pharmaceutical therapy, counseling, and nicotine replacement therapy. This study will identify this cohort's preferences for smoking cessation strategies. We will then examine the impact of utilizing patient preferences upon cessation efficacy by directly comparing cessation success in this study with our recently completed study of the same population using the same tobacco treatments which were randomly assigned.
Primary Outcome
Proportion of participants that quit smoking at the 8 week assessment
Conditions Studied
Interventions
- DRUG Varenicline
- DRUG Bupropion
- DRUG Long-acting nicotine replacement therapy
- BEHAVIORAL Low-intensity counseling
- BEHAVIORAL High-intensity counseling
Study Locations (3)
Kentucky
- Med Center Health - Bowling Green
- University Of Kentucky, Markey Cancer Center - Lexington
- Owensboro Health Mitchell Memorial Cancer Center - Owensboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2021-01-12 |
| Est. Completion | 2026-01-02 |
| Phase | Phase 2 |
What the finished NCT04634071 record still lists
NCT04634071 is an interventional study that assigns participants to a tested intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (73% lower).
The record links to 2 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 5 interventions - of which Varenicline is the first listed.
NCT04634071 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT04634071 about?
NCT04634071 is a clinical study titled "Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment". Smoking cessation has been shown to improve the effectiveness and reduce the morbidity of tobacco-related cancer treatments. We will identify effective smoking cessation strategies for patients who are receiving treatment for tobacco-related cancer. In this trial, patients' preferences in smoking ce...
What is the current status of trial NCT04634071?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 126 participants. The study started on 2021-01-12. Estimated completion is 2026-01-02.
What conditions does trial NCT04634071 study?
This clinical trial studies the following conditions: Smoking Cessation, Cancer, Treatment-Related.
What interventions are being tested in trial NCT04634071?
The interventions under investigation include: Varenicline (DRUG), Bupropion (DRUG), Long-acting nicotine replacement therapy (DRUG), Low-intensity counseling (BEHAVIORAL), High-intensity counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT04634071?
This trial is sponsored by Joseph Valentino, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04634071 being conducted?
This trial has 3 study locations across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04634071's enrollment target sits among peer trials
126 107th of 188 higher than 82 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity
RECRUITING · Phase 2
-
Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study
RECRUITING · Phase 2
-
Proof-Of-Concept Investigation With a Neurosteroid Analog (Ganaxolone) as a Smoking Cessation Candidate
COMPLETED · Phase 2
-
Treating Smokers With Mental Illness
COMPLETED · Phase 2
-
Suvorexant to Reduce Symptoms of Nicotine Use
COMPLETED · Phase 2
-
Pharmacogenetics, Emotional Reactivity and Smoking
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI